Cardiopulmonary Complications of Sickle Cell Disease in Children
Open Access
- 31 May 2024
- book chapter
- Published by IntechOpen
Abstract
Sickle cell disease (SCD) is an autosomal recessive hemoglobinopathy leading to hemolysis, increased endothelial adhesion, inflammation, and vasculopathy. While most children with SCD have normal pulmonary function, lung capacity and expiratory flows are lower compared to age- and racially matched controls. Airway obstruction dominates in children, with restrictive ventilatory defects becoming more prevalent in adolescents and young adults. Decreased pulmonary function, physician-diagnosed asthma, airway hyperresponsiveness, wheezing, and sleep-disordered breathing are associated with more frequent episodes of acute chest syndrome and vaso-occlusive crisis. Chronic lung disease, thromboembolism, hypoxemia, and sleep-disordered breathing are associated with the development of pulmonary hypertension and ventricular dysfunction which carry significant morbidity and mortality risk in adults. Most treatments for cardiopulmonary complications of SCD are based on guidelines developed for the general population. Although most guidelines do not recommend routine screening of asymptomatic children, patients with cardiopulmonary symptoms should be monitored and treated by subspecialists in a multidisciplinary setting. Disease modifying treatments such as hydroxyurea are attenuating some of the cardiopulmonary complications in SCD. More studies need to be done to assess the effects of newer disease modifying treatments targeting hemolysis and decreasing endothelial adhesion.Keywords
This publication has 101 references indexed in Scilit:
- Pediatric Obstructive Sleep Apnea and Sickle Cell Disease: Demographic and Polysomnographic FeaturesThe Laryngoscope, 2023
- Incidence of Acute Chest Syndrome in Children With Sickle Cell Disease Following Implementation of the 13-Valent Pneumococcal Conjugate Vaccine in FranceJAMA Network Open, 2022
- Management of Sickle Cell DiseaseJAMA, 2014
- Mortality in Adults With Sickle Cell Disease and Pulmonary HypertensionJAMA, 2012
- Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron depositionPediatric Blood & Cancer, 2010
- Evaluation of left ventricular diastolic function in pediatric sickle cell disease patientsAmerican Journal of Hematology, 2007
- N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell DiseaseJAMA, 2006
- Cardiac abnormalities in children with sickle cell anemiaAmerican Journal of Hematology, 2002
- Mechanisms of nocturnal oxyhemoglobin desaturation in children and adolescents with sickle cell diseasePediatric Pulmonology, 1999
- Lung function in infants with sickle cell diseasePediatric Pulmonology, 1997